Dentium (A145720) Q3 2024 earnings summary

Executive summary

• Specializes in dental implants and digital dental equipment, with 89% of sales from implants and 77% of revenue from overseas markets, especially China and Asia.

• Maintains the second-largest market share domestically and sixth globally, with a strong presence in China (25% share).

• Expanded business scope to include digital dentistry, synthetic bone, and new ventures in hydrogen fuel cells and dental interior construction.

Financial highlights

• 2024 Q3 consolidated revenue: ₩289.1B, down from ₩393.2B in 2023 Q3.

• Operating profit for 2024 Q3: ₩71.3B, net profit: ₩51.7B, both lower than 2023 Q3 (₩138.3B and ₩96.5B, respectively).

• Basic EPS for 2024 Q3: ₩6,029, compared to ₩11,193 in 2023 Q3.

• Gross margin remains robust, with a focus on high value-added products.

Outlook and guidance

• Plans to strengthen domestic market position and expand in China, Asia, and the Middle East.

• Expects new hydrogen fuel cell business to contribute from 2026, with ongoing R&D investments.

• Anticipates continued global dental market growth, especially in emerging markets.